Hangzhou Tigermed Consulting Co., Ltd. has issued a proxy circular for its 2026 Third H Share Class Meeting, scheduled for 23 September 2026 at the company’s headquarters (6/F, No. 508 Lujiatian Street, Puyan Sub-District, Binjiang District, Hangzhou, PRC). The session will convene immediately after the conclusion of both the 2026 Third Extraordinary General Meeting and the 2026 Third A Share Class Meeting.

Key items tabled for H-shareholder approval are:

1. Cancellation of Repurchased Shares and Registered Capital Reduction • Shareholders will vote on altering the use of a portion of shares previously repurchased by the company. • Approval would authorise the cancellation of these shares and trigger a corresponding reduction in registered capital.

2. Granting a General Mandate for Further A-Share Repurchases • The Board seeks authority to carry out additional on-market buy-backs of A shares within limits to be set at the meeting.

Shareholders of H shares may appoint the meeting chairman or another proxy to vote on their behalf. Valid proxy forms, together with any required powers of attorney, must reach Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong) no later than 24 hours before the meeting.

Identification documents are required for entry, and joint holders will have voting rights exercised by the first-named shareholder present. The proxy materials were dispatched on 3 September 2026, in line with statutory notice periods for Hong Kong-listed entities.